Infutraze

Zinc Chloride, Potassium Iodide, Sodium Selenite, Copper Chloride Dihydrate, Manganese Chloride Tetr, the active ingredients in Infutraze, are trace element supplements presented as a sterile solution for intravenous use. They address trace element deficiencies in patients receiving parenteral nutrition, especially in critical‑care and postoperative settings.

GNH USA supplies Infutraze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, intensive‑care units and clinics worldwide.

Infutraze is used to correct trace element deficits in patients receiving parenteral nutrition and related critical‑care conditions.

Parenteral nutrition: supplementation of essential trace elements in patients on total parenteral nutrition. Trace element deficiency: correction of low zinc, iodine, selenium, copper or manganese levels. Critical care nutrition: support of metabolic processes in intensive‑care patients requiring intravenous feeding.

Infutraze may be associated with infusion‑related and systemic reactions.

Common Side Effects: - Mild infusion site erythema or pain. - Transient fever or chills. - Nausea or mild gastrointestinal discomfort. - Headache. - Metallic taste. - Slight elevation of serum copper or zinc levels.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Significant electrolyte imbalance (e.g., hyper‑ or hypomagnesemia). - Hepatic dysfunction or elevated liver enzymes. - Copper or selenium toxicity with prolonged high‑dose exposure. - Severe thrombophlebitis at the infusion site. - Acute renal impairment in patients with pre‑existing kidney disease.

Infutraze should be used with careful clinical monitoring.

Monitor trace element levels: regularly assess serum zinc, copper, selenium, manganese and iodine. Assess renal function: adjust use in patients with impaired kidney function. Evaluate hepatic status: watch for liver enzyme changes during therapy. Caution with thyroid disorders: iodine content may affect thyroid hormone balance. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Infutraze can interact with other medications and nutrient solutions.

Major Interactions (Avoid): - Concurrent high‑dose copper or selenium supplements. - Co‑administration with other intravenous trace‑element solutions. - High‑dose zinc preparations that may cause copper deficiency. - Certain antibiotics (e.g., tetracyclines) that chelate metal ions. - Parenteral nutrition formulas with excessive zinc content.

Moderate Interactions (Monitor Closely): - Diuretics that alter electrolyte balance. - Thyroid hormone therapy (iodine may influence dosing). - Antacids containing aluminum or magnesium. - ACE inhibitors or ARBs affecting renal handling of electrolytes. - Immunosuppressants where trace‑element status may affect drug metabolism.